Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Biostorage Technologies Announces Growth into China

Published: Thursday, October 17, 2013
Last Updated: Thursday, October 17, 2013
Bookmark and Share
Partners with Charles River Labs to expand sample management in the region.

BioStorage Technologies has announced that it has received a business license from the Chaoyang Commission of Commerce to provide comprehensive sample management solutions in Beijing, China.

Through an exclusive partnership with Charles River Laboratories, BioStorage Technologies will provide technical consulting on sample management best practices, while Charles River Laboratories will host the physical storage of biological samples at their facility in Beijing.

As part of this collaboration, both companies will focus on expanding sample management solutions to global biopharmaceutical companies interested in conducting research in China.

Charles River Laboratories brings to the partnership its established life science research business infrastructure, relationships and leadership position in biopharmaceutical research within China.

BioStorage Technologies brings expertise in best-in-class sample storage, logistics and sample management technology solutions to global biopharmaceutical research and development companies, enabling them to expand their biopharmaceutical discovery and research within China.

“China represents an important opportunity for BioStorage Technologies as the region has experienced extreme growth in biopharmaceutical drug development in recent years,” said Greg Swanberg, CEO, BioStorage Technologies.

Swanberg continued, “We are honored to partner with an industry leader such as Charles River with the capabilities and infrastructure that allows us to bring technical expertise, world-class processes and technology platforms closer to the organizations conducting research in China.”

For biopharmaceutical companies conducting clinical trials in China, complex shipping regulations have led to difficulties in exporting biological samples outside of the region. As a result, there is a need for a local solution for sample management and temperature-controlled storage.

“Our partnership with BioStorage Technologies underscores our commitment to provide our global customers with best-in-class services throughout every facet of their early-stage drug development as well as clinical sample analysis and storage,” said Terrence Fisher, General Manager, Charles River Laboratories.

Fisher continued, “Through this agreement, which leverages BioStorage Technologies’ proven sample storage platform, we can provide our clients in China with quick access to and increased visibility into sample inventory data, as well as unsurpassed storage processes for managing their research samples.”

As a trusted partner to many of the industry’s largest biopharmaceutical companies, BioStorage Technologies manages the complete lifecycle of biological samples used in medical research.

From early-phase discovery to late-phase drug development, BioStorage Technologies is focused on reducing sample management risk and costs by providing consulting, innovative technology and flexible service model solutions.

As a global expert in sample management, BioStorage Technologies complies with regulations in North America, Europe, Asia-Pacific and many other regions.

The company adheres to GxP (GLP, GTP, GCP, GMP) compliance, has been the pioneer of Good Storage Practices (GSP) and follows all global import, export and transport guidelines such as the U.S. Department of Transportation and International Air Transport Association guidelines.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract
The U.S. Department of Veterans Affairs awarded a five-year contract for genotyping to the BioProcessing Solutions Alliance.
Friday, November 08, 2013
BioStorage Launches INTEGRITY Study
Measures effect of time, temperature and preparation methods on DNA and RNA samples.
Thursday, August 22, 2013
BioStorage Technologies Adding New Service in Germany
BioStorage Technologies announces the expansion of its temperature-controlled storage options to include vapor-phase liquid nitrogen preservation at its state-of-the-art biorepository facility in Griesheim, Germany.
Wednesday, October 17, 2012
BioStorage Expands its Service Offering to Include Advanced Bioprocessing Solutions
Company has developed a strategic and innovative alliance with RUCDR Infinite Biologics.
Wednesday, August 22, 2012
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos